NCT06222606 Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism
| NCT ID | NCT06222606 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Aarhus University Hospital |
| Condition | Thyroid Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2024-01-01 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to test if use of autofluorescence imaging (AF) reduces the risk of developing hypoparathyroidism (hypoPT) following surgery for thyroid cancer, either total thyroidectomy (TT) or completion hemithyroidectomy (cHT).
Eligibility Criteria
Inclusion Criteria: * Age\>18 years and able to give informed consent. * Suspicion or diagnosis of thyroid cancer. * Planned total thyroidectomy or completion thyroidectomy. * Normocalcemia prior to surgery. Exclusion Criteria: * Planned simultaneous parathyroid surgery. * Treatment with active vitamin D analogues. * eGFR \< 30.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06222606 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Thyroid Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06222606 currently recruiting?
Yes, NCT06222606 is actively recruiting participants. Contact the research team at jaclil@rm.dk for enrollment information.
Where is the NCT06222606 trial being conducted?
This trial is being conducted at Aarhus, Denmark.
Who is sponsoring the NCT06222606 clinical trial?
NCT06222606 is sponsored by Aarhus University Hospital. The trial plans to enroll 160 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.